• CA-074 Me: Strategic Inhibition of Cathepsin B in Necroptosi

  2026-05-13

  Explore the mechanistic, experimental, and translational dimensions of CA-074 Me—a potent, cell-permeable cathepsin B inhibitor—in unraveling necroptosis, apoptosis, and inflammation. This article bridges foundational insights with actionable strategies for translational researchers, incorporating recent advances and practical guidance to maximize the impact of lysosomal enzyme inhibition in disease models.

• RSL3 Glutathione Peroxidase 4 Inhibitor: Protocols & Tumor R

  2026-05-13

  The (1S,3R)-RSL3 glutathione peroxidase 4 inhibitor empowers researchers to induce ferroptosis with high specificity in RAS-driven tumor models. This article delivers actionable protocol enhancements, troubleshooting strategies, and translational guidance for maximizing RSL3's impact in cancer biology and oxidative stress modulation.

• Nanocrystal Formulation Enhances Ziprasidone HCl Cell Permea

  2026-05-12

  Karaküçük et al. investigated nanocrystal formulations of ziprasidone hydrochloride monohydrate (ZHM) and found a 2.3-fold increase in Caco-2 cell permeability compared to coarse powder, with no cytotoxicity. These findings directly address bioavailability limitations of ZHM, informing future development of antipsychotic and translational research workflows.

• Quercetin Inhibits Ferroptosis to Mitigate Liver Injury in W

  2026-05-12

  This study systematically demonstrates that quercetin alleviates liver injury in Wilson's disease by directly inhibiting the ACSL4/LPCAT3/ALOX15-mediated ferroptosis pathway. These findings provide mechanistic evidence for ferroptosis-targeted therapies and position quercetin as a multi-target modulator for hepatic protection in metal overload conditions.

• Methyl-β-cyclodextrin: Technical Guidance for Membrane Studi

  2026-05-11

  Methyl-β-cyclodextrin (SKU C6939) is a high-purity reagent for extracting cholesterol and select lipids from cellular membranes, enabling researchers to control membrane fluidity and study lipid raft dynamics. It is intended for laboratory research use only and should not be used in diagnostic or therapeutic applications.

• T7 RNA Polymerase: Mechanism, Evidence, and Workflow Integra

  2026-05-11

  T7 RNA Polymerase is a recombinant enzyme expressed in E. coli, highly specific for T7 promoter-driven in vitro transcription. Its robust activity underpins RNA synthesis for research and RNA vaccine production. We summarize its molecular mechanism, evidence base, and best-practice usage parameters.

• SCUBE3 Antibody Targeting Disrupts Oncogenic Signaling in Ca

  2026-05-10

  This study identifies secretory SCUBE3 as a pivotal driver of tumor growth, therapy resistance, and immune evasion in multiple cancer types. Antibody-mediated targeting of SCUBE3 disrupts oncogenic signaling via EGFR and related pathways, restores antitumor immunity, and demonstrates broad preclinical efficacy, highlighting SCUBE3 as a promising therapeutic target.

• Aβ42 Peptide: Mechanistic Insights for Translational AD Rese

  2026-05-09

  This article delivers a thought-leadership perspective on Amyloid β-Peptide (1-42) (Aβ42) as a driver of Alzheimer’s disease mechanisms, bridging molecular insights with strategic guidance for translational researchers. It explores Aβ42’s dual roles in neurotoxicity and microglial activation, integrates recent reference findings, and provides actionable protocol parameters rooted in the latest evidence. Distinct from workflow guides, this piece frames the competitive landscape and articulates the translational impact of leveraging rigorously characterized peptides such as APExBIO’s Amyloid β-Peptide (1-42) (human).

• PFOS-Induced Ferroptosis and ER Stress in HK-2 Cells: Mechan

  2026-05-08

  This study rigorously demonstrates that perfluorooctane sulfonate (PFOS) induces injury in human renal proximal tubular (HK-2) cells through activation of ferroptosis and endoplasmic reticulum (ER) stress pathways. The findings provide mechanistic insight into PFOS nephrotoxicity, with practical implications for modeling ER stress in vitro and guiding the use of chemical chaperones for pathway dissection.

• Prednisolone in Glucocorticoid Signaling: Mechanistic Insigh

  2026-05-08

  Explore how Prednisolone, a synthetic glucocorticoid, advances glucocorticoid signaling and inflammation modulation research. This article uniquely connects small-molecule assay design with new protein degradation strategies.

• circHIF1A/miR-486-5p/GRHL2 Axis Drives LUAD Progression via

  2026-05-07

  This study uncovers how circHIF1A, acting through the miR-486-5p/GRHL2 axis, promotes macrophage M2 polarization and accelerates lung adenocarcinoma (LUAD) progression. These findings define a novel regulatory circuit within the tumor microenvironment, highlighting potential diagnostic markers and therapeutic targets for LUAD.

• Q-VD(OMe)-OPh: Optimizing Caspase Inhibition in Apoptosis As

  2026-05-07

  Q-VD(OMe)-OPh redefines caspase inhibition, enabling robust, non-toxic modulation of apoptosis in cell-based and in vivo models. This guide translates breakthrough experimental findings into actionable workflows and troubleshooting strategies for apoptosis, neuroprotection, and cancer resistance research.

• U0126 as a Precision Tool for Dissecting MAPK/ERK Pathway In

  2026-05-06

  Explore how U0126, a potent MEK1/2 inhibitor, enables advanced, reproducible MAPK/ERK signaling pathway inhibition in cancer biology and neuroinflammation research. This article uniquely bridges mechanistic depth with practical assay guidance.

• Alcohol and Anti-HIV Drugs Intensify Stress in Aging Liver C

  2026-05-06

  This study by Chen et al. provides mechanistic insight into how alcohol, anti-HIV drugs, and hippuric acid exacerbate cellular stress responses in senescent hepatocytes and aged mouse liver. The research highlights key protein changes that may underlie increased liver vulnerability in older individuals with HIV and substance use, revealing targets for further investigation in age-related hepatic injury.

• CA-074 Me: Precision Cathepsin B Inhibitor for Lysosomal Ass

  2026-05-05

  CA-074 Me empowers researchers to dissect cathepsin B-dependent cell death pathways with exceptional specificity and reproducibility. Its membrane permeability, selectivity, and robust inhibition profile make it the tool of choice for apoptosis, necroptosis, and inflammation research in both cellular and animal models.

8645 records 19/577 page Previous Next First page 上5页 1617181920 下5页 Last page